SCHEMBL7954884

SCHEMBL7954884

N#Cc1ccc(C(=O)N2CCN(c3ccncc3)CC2)cc1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SLC6A7 Q99884 3/20 0.63
▸ SMN1; SMN2 Q16637 2/20 0.62
▸ AKR1C3 P42330 1/20 0.62
▸ CYP3A4 P08684 6/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ GAA P10253 1/20 0.58
▸ NAMPT P43490 3/20 0.57
▸ CYP2D6 P10635 2/20 0.55
▸ CYP2C9 P11712 3/20 0.53
▸ CYP2C19 P33261 3/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ PDK1 Q15118 1/20 0.51
▸ PDK2 Q15119 1/20 0.51
▸ PDK3 Q15120 1/20 0.51
▸ PDK4 Q16654 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ POLB P06746 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3584765 0.84 NAMPT (0.61) SLC6A7SMN1; SMN2CYP3A4ALDH1A1GAA
SCHEMBL3640637 0.84 GRM5 (0.63) SLC6A7SMN1; SMN2AKR1C3CYP3A4ALDH1A1
SCHEMBL25160524 0.83 NAMPT (0.60) SLC6A7SMN1; SMN2AKR1C3ALDH1A1NAMPT
SCHEMBL20639683 0.83 GPR183 (0.64) SLC6A7SMN1; SMN2AKR1C3ALDH1A1NAMPT
SCHEMBL25160076 0.83 GPR183 (0.64) SLC6A7SMN1; SMN2AKR1C3ALDH1A1NAMPT
SCHEMBL94245 0.83 NAMPT (0.60) SLC6A7SMN1; SMN2ALDH1A1NAMPTHSD17B10
SCHEMBL20347007 0.83 LMNA (0.67) SLC6A7ALDH1A1NAMPTHSD17B10POLB
SCHEMBL7956560 0.82 KDM4E (0.65) SMN1; SMN2AKR1C3CYP3A4POLB
SCHEMBL15288936 0.82 MKNK1 (0.75) SLC6A7CYP3A4
SCHEMBL12082812 0.81 LMNA (0.69) SLC6A7SMN1; SMN2AKR1C3CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313127-B1 FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS ZENECA LIMITED (GB) 2001-11-06 — — US disclosed
EP-0880501-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1998-12-02 — — EP disclosed
WO-1997028128-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1997-08-07 — — WO disclosed
Send feedback